Overview

Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM

Status:
NOT_YET_RECRUITING
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This study aims to compare total intravenous anesthetic agents: combined remimazolam and propofol vs. propofol monotherapy. The comparison parameters are intraoperative hypotension, patient's involuntary movement, neurophysiological monitoring quality, onset time, recovery time, and postoperative rescue anti-emetics requirements.
Phase:
PHASE4
Details
Lead Sponsor:
Chung-Ang University Gwangmyeong Hospital
Treatments:
Propofol